MicrobioSeq represents the microbial genomics division of CD Genomics headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation in providing reliable sequencing, genotyping, microarray, and bioinformatics services. Nowadays, the company announced SMRT-based transcriptomics analysis, which is useful to identify novel transcript isoforms, fusion gene expression, and alternative splicing events, and also improve genome annotation.
Transcriptomics enables genome-wide analysis of transcription at single-nucleotide resolution, including determination of the relative abundance of transcripts, unbiased identification of alternative splicing events and post-transcriptional RNA editing events, and detection of single nucleotide polymorphisms (SNPs). While analyzing co-post-transcriptional processing events is difficult with the short-read sequencing, SMRT isoform sequencing (Iso-Seq) is a long-read sequencing strategy that can span the full length of transcripts. It is able to sequence the full-length isoforms without the need for assembly.
The SMRT-based transcriptomics platform provides a simple and accurate method for various applications, such as gene annotation, identification of transcript isoforms and fusion transcripts, long non-coding RNA (lncRNA) discovery, microRNA (miRNA) discovery, and prediction of potential mRNA target molecules. It also helps improve genome annotation by identifying gene structure, coding regions, and regulatory elements. SMRT-based transcriptomics can be used to solve various research problems such as early embryo development, phylogenetic inference, cell differentiation, biomarker discovery, drug target identification, etc.
“CD Genomics can help you with even the most challenging transcriptomics sequencing tasks. We can easily extract full-length cDNA sequences covering whole transcripts from the 5’ end to the 3’ poly-A tail utilizing PacBio SMRT sequencing without the requirement for fragmentation using our single molecule real-time (SMRT)-based transcriptomics analysis. This technique can be used to discover new transcript isoforms, fusion gene expression, and alternative splicing events, as well as to improve genome annotation. ” Said the Chief Scientist of CD Genomics.
What are the advantages of CD Genomics’s SMRT-Based Transcriptomics Analysis?
1.Strict quality control is applied during each operation to ensure precise and repeatable outcomes.
2.Learn about new genes, transcripts, and alternative splicing events.
3.Determine the structure of gene, the coding sections, and the regulatory elements.
4.The longest average read length and the highest consensus accuracy will be achieved.
“CD Genomics has been further developed based on extensive microbial genomics expertise, and its aim is to speed the whole microbiome industry toward breakthrough discoveries. CD Genomics has worked hard over the years to establish itself as a prominent provider of SMRT-based transcriptomics analysis for research institutions and biotech firms.” Said Dianna, Marketing Manager of CD Genomics.
About MicrobioSeq Divison of CD Genomics
MicrobioSeq is the microbial genomics division of CD Genomic, which is a genomics service company with a good reputation for providing reliable microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services.
Contact
Address: Shirley, NY 11967, USA
Email: [email protected]
